GSK plc (GSK)
Health Care
GSK is listed on the New York Stock Exchange, where its shares have traded since August 18, 1976. It represents shares of GSK plc, which reports its financial results in GBP. SentiSense covers it in the Health Care sector.
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Latest reported results
GSK plc reported revenue of 8.82 billion GBP for Q3 FY2026, up 3.2% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 1,027 institutions reported holding GSK, with 345.6 million shares worth $18.1 billion in aggregate. The largest reported holders were FMR, Dodge & Cox and Fisher Asset Management. Of the 5 largest reported holders, 1 added shares and 4 reduced their positions during the quarter.
More on GSK
- GSK sentiment: whether news and social coverage of GSK plc leans bullish or bearish, and the stories driving it.
- GSK ownership: all 1,027 reporting institutions, plus insider and congressional trades.
- GSK financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
SentiSense also tracks daily options readings for GSK plc: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does GSK plc do?
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales.
What sector is GSK in?
SentiSense classifies GSK plc in the Health Care sector.
Where does GSK stock trade?
GSK is listed on the New York Stock Exchange, where its shares have traded since August 18, 1976. It represents shares of GSK plc, which reports its financial results in GBP.
Who is the CEO of GSK plc?
Luke Miels is the chief executive officer of GSK plc.